We are live on ! Find out more
DHFB

Dixon Hubard Feinour & Brown Portfolio holdings

AUM $842M
1-Year Est. Return 2.74%
This Fund
S&P 500
This Quarter Est. Return
+3.89%
1 Year Est. Return
-2.74%
3 Year Est. Return
+59.78%
5 Year Est. Return
+118.87%
10 Year Est. Return
AUM
$322M
AUM Growth
+$9.28M
Cap. Flow
+$1.33M
Cap. Flow %
0.41%
Top 10 Hldgs %
24.44%
Holding
184
New
17
Increased
42
Reduced
59
Closed
13

Top Buys

Rank Stock Value
1
AMGN icon
Amgen
AMGN
+$6.21M
2
ACN icon
Accenture
ACN
+$5.86M
3
LH icon
Labcorp
LH
+$5.52M
4
EA
Electronic Arts
EA
+$5.12M
5
LRCX icon
Lam Research
LRCX
+$4.42M

Top Sells

Rank Stock Value
1
CVS icon
CVS Health
CVS
+$7.03M
2
KR icon
Kroger
KR
+$5M
3
MHK icon
Mohawk Industries
MHK
+$4.88M
4
SLB icon
SLB Ltd
SLB
+$3.51M
5
MPC icon
Marathon Petroleum
MPC
+$3.5M

Sector Composition

Rank Sector Weight
1 Healthcare 25.09%
2 Technology 14.53%
3 Industrials 11.48%
4 Communication Services 9.95%
5 Consumer Discretionary 6.61%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MIN
101
Aberdeen Intermediate Income Fund
MIN
$277M
$688K 0.21%
151,940
+8,000
+6% +$36.8K
YUM icon
102
Yum! Brands
YUM
$41.4B
$681K 0.21%
10,438
BNCN
103
DELISTED
BNC Bancorp
BNCN
$676K 0.21%
27,788
-3,589
-11% -$86.4K
COP icon
104
ConocoPhillips
COP
$140B
$666K 0.21%
15,325
-835
-5% -$34.7K
EQT icon
105
EQT Corp
EQT
$32.4B
$655K 0.2%
16,561
ZTS icon
106
Zoetis
ZTS
$31.8B
$613K 0.19%
11,785
SLB icon
107
SLB Ltd
SLB
$76.2B
$565K 0.18%
7,186
-44,161
-86% -$3.51M
VIG icon
108
Vanguard Dividend Appreciation ETF
VIG
$114B
$554K 0.17%
6,600
PM icon
109
Philip Morris
PM
$295B
$546K 0.17%
5,612
-550
-9% -$55.1K
JPM icon
110
JPMorgan Chase
JPM
$948B
$523K 0.16%
7,849
NOC icon
111
Northrop Grumman
NOC
$80B
$508K 0.16%
2,375
VGK icon
112
Vanguard FTSE Europe ETF
VGK
$31.4B
$499K 0.15%
10,236
-349
-3% -$16.8K
FIS icon
113
Fidelity National Information Services
FIS
$22.2B
$494K 0.15%
6,414
EMD
114
Western Asset Emerging Markets Debt Fund
EMD
$616M
$493K 0.15%
30,335
+125
+0.4% +$2.02K
TT icon
115
Trane Technologies
TT
$106B
$492K 0.15%
7,242
+2,350
+48% +$157K
CAT icon
116
Caterpillar
CAT
$385B
$485K 0.15%
5,464
+2,390
+78% +$196K
STI
117
DELISTED
SunTrust Banks, Inc.
STI
$478K 0.15%
10,905
-20
-0.2% -$857
KMB icon
118
Kimberly-Clark
KMB
$36.3B
$468K 0.15%
3,710
+150
+4% +$19.4K
OEF icon
119
iShares S&P 100 ETF
OEF
$20.5B
$417K 0.13%
4,345
ABT icon
120
Abbott
ABT
$186B
$409K 0.13%
9,670
VNO icon
121
Vornado Realty Trust
VNO
$7.41B
$399K 0.12%
4,873
STBA icon
122
S&T Bancorp
STBA
$1.81B
$395K 0.12%
13,626
JCI icon
123
Johnson Controls International
JCI
$92.7B
$387K 0.12%
8,327
-1,199
-13% -$55.6K
APD icon
124
Air Products & Chemicals
APD
$66.9B
$380K 0.12%
2,730
WB icon
125
Weibo
WB
$1.95B
$356K 0.11%
7,100

Similar funds

Dixon Hubard Feinour & Brown's Q3 2016 Portfolio in Review

As of Q3 2016, Dixon Hubard Feinour & Brown held 184 positions worth $322M, up 3% from $313M the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Dixon Hubard Feinour & Brown's Q3 2016 filing shows 17 new, 42 increased, 59 reduced and 13 closed positions. Its largest new stake was Amgen: 36,700 shares worth $6.12M. The largest sale was CVS Health, an estimated $7.03M.

By sector, the portfolio is most concentrated in Healthcare at 25% of assets, up from 25% a quarter earlier, followed by Technology and Industrials.

  • Dixon Hubard Feinour & Brown's largest Q3 2016 buy was Amgen: 36,700 shares worth $6.12M.
  • Dixon Hubard Feinour & Brown added most to Travelers Companies in Q3 2016, an estimated $821K increase.
  • Dixon Hubard Feinour & Brown's biggest Q3 2016 reduction was SLB Ltd, cutting an estimated $3.51M.
  • Dixon Hubard Feinour & Brown fully exited CVS Health in Q3 2016, selling an estimated $7.03M.
  • Dixon Hubard Feinour & Brown's ten largest holdings make up 24% of its $322M portfolio in Q3 2016.
  • Dixon Hubard Feinour & Brown opened 17 new positions and closed 13 in Q3 2016.
  • Dixon Hubard Feinour & Brown's portfolio value rose 3% quarter-over-quarter to $322M.

Based on Dixon Hubard Feinour & Brown's 13F filing for Q3 2016, filed 9 Nov 2016.